SCHEMBL26077210

SCHEMBL26077210

COC(=O)c1cc(Cl)nc(Oc2cnc(N3CCCCC3)nc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 3/20 0.47
ALDH1A1 P00352 4/20 0.43
NPSR1 Q6W5P4 3/20 0.43
TSHR P16473 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.39
FURIN P09958 3/20 0.39
TAS1R3 Q7RTX0 1/20 0.39
TAS1R1 Q7RTX1 1/20 0.39
TAS1R2 Q8TE23 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
POLB P06746 1/20 0.38
ESR1 P03372 1/20 0.37
OGA O60502 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26077216 1.00 GPR119 (0.47) GPR119ALDH1A1NPSR1TSHRL3MBTL1
SCHEMBL26077253 0.89 GPR119 (0.45) GPR119ALDH1A1L3MBTL1MAPTKDM4E
SCHEMBL21551107 0.89 GPR119 (0.45) GPR119ALDH1A1NPSR1TSHRL3MBTL1
SCHEMBL21551697 0.88 GPR119 (0.47) GPR119ALDH1A1L3MBTL1KDM4EFURIN
SCHEMBL26077259 0.88 GPR119 (0.43) GPR119ALDH1A1L3MBTL1KDM4EFURIN
SCHEMBL26077220 0.86 GPR119 (0.51) GPR119ALDH1A1NPSR1TSHRL3MBTL1
SCHEMBL26077217 0.86 FURIN (0.52) GPR119ALDH1A1NPSR1TSHRFURIN
SCHEMBL26077211 0.86 FURIN (0.52) GPR119ALDH1A1NPSR1TSHRFURIN
SCHEMBL21551729 0.85 GPR119 (0.46) GPR119MAPT
SCHEMBL29890912 0.85 GPR119 (0.46) GPR119MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 GPR119 2318/4885ALDH1A1 3733/4885NPSR1 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.